Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03877146 · ClinicalTrials.gov registry record · NA

Calming Alternatives Learned During MRI-Guided Breast Biopsy

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
58
Enrollment target

NCT03877146 is a NA study that has completed, run by Duke University. The registered enrollment target is 58 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03877146, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
58 participants
Enrollment target

Study Summary

The proposed randomized study evaluates whether a controlled breathing intervention could be efficacious for reducing pain in the MRI-guided breast biopsy setting. Support for this intervention stems from experimental and clinical studies on the effects of controlled breathing on pain. Implementing a controlled breathing intervention during MRI-guided breast biopsy has the potential to provide effective pain management in this outpatient setting. The primary study objectives are to assess the feasibility, acceptability, and efficacy of a novel audio-recorded controlled breathing intervention for reducing breast and body pain in women undergoing MRI-guided breast biopsy. The secondary study objectives are to evaluate the effects of controlled breathing on measures of physiological reactivity (i.e., blood pressure and heart rate), pain catastrophizing, and self-efficacy for pain and anxiety.

Interventions

  • BEHAVIORAL Controlled Breathing Intervention

Trial Details

FieldValue
Enrollment Target 58 participants
Start Date 2018-10-16
Est. Completion 2019-06-20
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT03877146

The ClinicalTrials.gov registry entry for NCT03877146 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Controlled Breathing Intervention is the first listed.

NCT03877146 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03877146 about?

NCT03877146 is a clinical study titled "Calming Alternatives Learned During MRI-Guided Breast Biopsy". The proposed randomized study evaluates whether a controlled breathing intervention could be efficacious for reducing pain in the MRI-guided breast biopsy setting. Support for this intervention stems from experimental and clinical studies on the effects of controlled breathing on pain. Implementing ...

What is the current status of trial NCT03877146?

This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2018-10-16. Estimated completion is 2019-06-20.

What interventions are being tested in trial NCT03877146?

The interventions under investigation include: Controlled Breathing Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03877146?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.